Melanotan 2 FAQ — Research Questions Answered from the Published Literature
Frequently Asked Questions
The following questions about Melanotan 2 (MT-II) are answered directly from the published research literature. Every quantitative claim is cited. This is editorial commentary on the science — not medical advice.
What is Melanotan 2?
Melanotan 2 (MT-II) is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (alpha-MSH). Developed at the University of Arizona, it was designed to be more potent and metabolically stable than native alpha-MSH. Its full sequence is Ac-Nle4-cyclo[Asp5-His6-D-Phe7-Arg8-Trp9-Lys10]-NH2. It binds MC1R, MC3R, MC4R, and MC5R and has been studied primarily for melanogenesis stimulation, erectile function, and appetite modulation [1][18].
How long does Melanotan 2 take to tan?
In the Dorr 1996 Phase I study, five subcutaneous doses over ten days produced measurable reflectance-based pigmentation increases within 2–3 weeks [1]. Individual response varied with baseline Fitzpatrick skin type. Exact timelines were not formally characterized in the three-subject pilot.
Does Melanotan 2 affect the kidneys?
A 2020 case report documented right-sided renal infarction affecting approximately 50% of kidney tissue in a patient after self-administering 27 mg of MT-II subcutaneously over six months [4]. The proposed mechanisms include thrombotic pharmacological influence and direct nephrotoxic effect. Human safety data remain very limited; this was the first published renal infarction case in the Swedish Poison Center's record of 215 MT-II exposures.
Does Melanotan 2 lower testosterone?
No peer-reviewed study has demonstrated MT-II lowering testosterone in humans. Raposinho 2003 documented in rats that central MT-II infusion counteracted NPY-driven hyperphagia but did not affect LH pulsatility, suggesting the gonadotropic axis operates independently of melanocortinergic feeding modulation [14]. Direct testosterone suppression has not been a reported finding in published human or animal MT-II literature.
Does Melanotan 2 make your hair darker?
MC1R activation can in principle stimulate melanin synthesis in hair follicle melanocytes. Case reports and user forum observations mention hair darkening following MT-II use [7]. No controlled human study measuring hair pigmentation as an endpoint has been published. The effect is biologically plausible but not formally characterized in the research record.
Does Melanotan cause fat loss?
MC4R agonism by MT-II reduces food intake in rodent models, and chronic central melanocortin activation produces persistent body mass reduction. Cote 2017 documented that 40-day central melanocortin activation in rats reduced intra-abdominal fat by 35–55% and produced 3-fold elevation in brown adipose tissue thermogenesis, even after food intake returned to baseline [5]. Tolerance to the anorexic effect developed within 5 days; the thermogenic effect persisted.
Does Melanotan 2 increase dopamine?
Central melanocortin receptor signaling interacts with dopaminergic and oxytocinergic pathways. Thurston 2022 demonstrated in a 31-subject randomized trial that MC4R agonism enhanced amygdala-insula connectivity during erotic stimuli [11]. Paiva 2017 documented increased oxytocin neuron firing rates following IV MT-II in rats [15]. Direct dopamine measurement data for human MT-II administration are not published.
Does Melanotan 2 change eye color?
There is no peer-reviewed evidence that MT-II changes iris color. Iris color is genetically determined by melanocyte number and melanin content across the iris stroma; adult iris color change is not a documented outcome in any published MT-II trial or case series. User-reported observations of iris color change lack controlled study validation.
How long until Melanotan 2 starts working?
Transient effects — nausea, flushing, spontaneous erections — emerged within 30–60 minutes of subcutaneous injection in the Dorr 1996 human trial [1]. Pigmentation changes were measurable at 2–3 weeks. The plasma half-life is approximately 1 hour based on available pharmacokinetic data [16]; melanogenic effects persist far longer because eumelanin is deposited in skin cells that remain long after peptide clearance.
How many ml of melanotan 2 should I take?
The Dorr 1996 Phase I study used 0.01 mg/kg subcutaneously, and the Wessells 1998 erectile function study used 0.025 mg/kg [1][2]. The volume of solution depends on the reconstitution concentration used in the specific research protocol. This site covers research-described protocols only and does not provide human use recommendations. MT-II is unapproved for any human indication.
How much Melanotan 2 should be used?
Published human studies used weight-based doses of 0.01–0.025 mg/kg administered subcutaneously [1][2][3]. No approved human dosing protocol exists; MT-II has not received regulatory approval anywhere. All dosing figures on this site are from published research protocols. This is not a prescriptive reference.
What is the difference between Melanotan 1 and Melanotan 2?
MT-I (afamelanotide) is a linear 13-amino-acid alpha-MSH analog that is primarily MC1R-selective. MT-II is a cyclic 7-amino-acid analog that activates MC1R, MC3R, MC4R, and MC5R. Afamelanotide received EMA approval for erythropoietic protoporphyria; MT-II remains unapproved globally. The clinical program most directly derived from MT-II is bremelanotide (PT-141), a cyclic metabolite that received FDA approval in 2019 for HSDD.
Is Melanotan II truly dangerous?
MT-II is not approved by any regulatory authority. Published case reports document renal infarction [4], histologically confirmed melanoma [9], dysplastic nevus transformation [8][20], and ischemic priapism requiring surgery [10]. Regulatory agencies including TGA and MHRA have issued enforcement warnings. The research literature does not support a characterized human safety profile; the adverse-event record is real but limited in scale.
How long do tanning injections last?
In the Dorr 1996 study, pigmentation increases persisted beyond the active dosing period [1]. Formal maintenance and decay timelines have not been characterized in controlled human studies. Animal models and observational data suggest melanin accumulation gradually fades over weeks to months following cessation.
Does Melanotan increase testosterone?
No published study confirms MT-II increases testosterone. Raposinho 2003 documented in rats that MC4R-mediated melanocortin feeding modulation does not affect LH pulsatility or the somatotropic axis, suggesting the melanocortin and gonadotropic pathways are pharmacologically distinct under these conditions [14]. A direct testosterone-elevating effect has not been established.
Will melanotan be widely used for skin cancer prevention?
MT-I (afamelanotide), not MT-II, is the compound receiving regulatory attention in photoprotection. Afamelanotide is approved by the EMA for erythropoietic protoporphyria and has been studied as a UV-protective agent. MT-II lacks the receptor selectivity and characterized safety profile needed for approval as a preventive agent. Current research on pharmacological photoprotection focuses on afamelanotide.
Where are melanotan injections derived from or made out of?
MT-II is a fully synthetic cyclic heptapeptide (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2) produced by solid-phase peptide synthesis. It is not derived from any biological source. It was designed chemically at the University of Arizona as a truncated, cyclized, potency-optimized analog of alpha-MSH.
Is melanotan which increases melanin in skin safe to use?
MT-II has not been approved by any regulatory body. The available human data are limited to two small early-phase trials and a growing case-report literature documenting nausea, spontaneous erections, flushing, renal infarction, melanoma, dysplastic nevi, and priapism as adverse events [1][2][3][4][8][9][10]. Product quality in the unregulated market is variable; forensic analysis found ~30% purity in tested vials [17].
What is Melanotan 2 used for?
Published research has studied Melanotan 2 for melanogenesis stimulation (UV-independent tanning) [1], erectile dysfunction via MC4R [2][3], appetite modulation via central melanocortin circuits [5][6], neuroprotection in peripheral nerve injury [13], and insulin sensitivity in rodent models [12]. None of these applications have reached regulatory approval for MT-II.
How much melanotan 2 to inject in research studies?
Published Phase I and Phase II human studies used 0.01 mg/kg to 0.025 mg/kg subcutaneously [1][2][3]. Rodent efficacy studies used a broader dose range depending on the model and route. No approved dosing protocol exists for humans.
How to reconstitute melanotan 2 for research?
Published research protocols describe reconstitution of lyophilized MT-II in sterile water or bacteriostatic saline. Specific preparation details should be drawn from the methodology sections of published studies. Oral bioavailability in rats is 4.6% [16], which is why parenteral routes are used in all clinical-stage human research.
Where to inject melanotan 2 in animal models?
Animal studies have used subcutaneous, intravenous, intracerebroventricular, and intranasal administration. The Dorr 1996 and Wessells 1998/2000 human trials used subcutaneous injection [1][2][3]. Paiva 2017 showed that intranasal administration in rats did not replicate the central Fos induction produced by IV administration [15].
What is melanotan 2 half life?
Plasma half-life is approximately 1 hour based on rat IV pharmacokinetic data (Ugwu 1994) [16]. MT-II's cyclic structure confers approximately 4–6-fold greater metabolic stability than linear alpha-MSH (~10–15 min). Melanogenic effects persist far longer than plasma presence, because eumelanin already deposited in skin remains through normal cellular turnover.
Does Melanotan 2 affect the liver?
Liver-specific toxicity has not been a primary finding in published MT-II case reports or trials. The documented serious adverse events focus on renal and cardiovascular effects [4][10]. Liver function was not a primary endpoint in the Dorr or Wessells trials. The absence of hepatotoxicity reports reflects the limited scale of the published safety dataset rather than a formal hepatic safety assessment.
What melanocortin receptors does Melanotan 2 bind?
MT-II binds MC1R (pigmentation), MC3R (energy homeostasis), MC4R (sexual function, appetite, autonomic tone), and MC5R (exocrine gland function). It is a non-selective melanocortin agonist; MC4R agonism drives the central effects (erectile response, appetite suppression) documented in the Wessells [2][3] and Cote [5] studies. The melanocortin receptor binding profile page details the receptor pharmacology.
What has been your experience with using Melanotan 2?
Published case series and pharmacovigilance data document commonly reported effects including nausea within 1 hour of injection, transient flushing, spontaneous erections, and visible skin darkening over 2–4 weeks. Gilhooley 2021's qualitative study of 623 forum posts from 205 users identified these as the most commonly reported experiential observations [7]. These are post-market case reports, not controlled trial outcomes.